Molecular engineering of an EGFP/disintegrin-based integrin marker

Toxicon

Volumn 46, Issue 2, 2005, Pages 178-184

  Butera, Diego ^a,b,c   Fontes Piazza, Roxane Maria ^a   McLane, Mary Ann ^d   Chammas, Roger ^b,c   Da Silva, Ana Maria Moura ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Center for Cell Therapy and Regional Blood Center   (Brazil)

^d UNIVERSITY OF DELAWARE   (United States)

Author keywords

Biomarker; Disintegrins; EGFP; GPIIb IIIa; Integrins

Indexed keywords

ALPHA2 INTEGRIN; DISINTEGRIN; ENHANCED GREEN FLUORESCENT PROTEIN; ERISTOSTATIN; HYBRID PROTEIN; INTEGRIN; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

AFFINITY CHROMATOGRAPHY; ARTICLE; BIOASSAY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; EXPRESSION VECTOR; FLUORESCENCE; HUMAN; HUMAN CELL; MOLECULAR CLONING; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RESTRICTION SITE; THROMBOCYTE; WESTERN BLOTTING;

ANIMALS; BIOLOGICAL MARKERS; BLOOD PLATELETS; BLOTTING, WESTERN; CHROMATOGRAPHY, AFFINITY; CLONING, MOLECULAR; DISINTEGRINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FLUORESCENCE; GENETIC ENGINEERING; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; MICROSCOPY, CONFOCAL; PEPTIDES; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; VIPER VENOMS;

VIPER;

EID: 22044436157     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2005.04.003     Document Type: Article

References (22)

1. D. Butera, K. Skielka, M.A. McLane, C. Paquette-Straub, F. Ducancel, and A.M. Moura-da-Silva Cloning, expression, and characterization of a bi-functional disintegrin/alkaline phosphatase hybrid protein Protein Expr. Purif. 31 2003 286 291
2. H.J. Cha, C.F. Wu, J.J. Valdes, G. Rao, and W.E. Bentley Observations of green fluorescent protein as a fusion partner in genetically engineered Escherichia coli: monitoring protein expression and solubility Biotechnol. Bioeng. 67 2000 565 574
3. Y.Q. Chen, M. Trikha, X. Gao, R. Bazaz, A.T. Porter, J. Timar, and K.V. Honn Ectopic expression of platelet integrin alphaIIb beta3 in tumor cells from various species and histological origin Int. J. Cancer 72 1997 642 648
4. B.P. Cormack, R.H. Valdivia, and S. Falkow FACS-optimized mutants of the green fluorescent protein (GFP) Gene 173 1996 33 38
5. B. Felding-Habermann, R. Habermann, E. Saldivar, and Z.M. Ruggeri Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow J. Biol. Chem. 271 1996 5892 5900
6. J.N. George, J.P. Caen, and A.T. Nurden Glanzmann's thrombasthenia: the spectrum of clinical disease Blood 75 1990 1383 1395
7. J.D. Hood, and D.A. Cheresh Role of integrins in cell invasion and migration Nat. Rev. Cancer 2 2002 91 100
8. M. Kinjo Lodgement and extravasation of tumour cells in blood-borne metastasis: an electron microscope study Br. J. Cancer 38 1978 293 301
9. M.A. McLane, M.A. Kowalska, L. Silver, S.J. Shattil, and S. Niewiarowski Interaction of disintegrins with the alpha IIb beta 3 receptor on resting and activated human platelets Biochem. J. 301 1994 429 436
10. M.A. McLane, S. Vijay-Kumar, C. Marcinkiewicz, J.J. Calvete, and S. Niewiarowski Importance of the structure of the RGD-containing loop in the disintegrins echistatin and eristostatin for recognition of alpha IIb beta 3 and alpha v beta 3 integrins FEBS Lett. 391 1996 139 143
11. M. Ormo, A.B. Cubitt, K. Kallio, L.A. Gross, R.Y. Tsien, and S.J. Remington Crystal structure of the Aequorea victoria green fluorescent protein Science 273 1996 1392 1395
12. M. Pfaff, M.A. McLane, L. Beviglia, S. Niewiarowski, and R. Timpl Comparison of disintegrins with limited variation in the RGD loop in their binding to purified integrins alpha IIb beta 3, alpha V beta 3 and alpha 5 beta 1 and in cell adhesion inhibition Cell Adhes. Commun. 2 1994 491 501
13. J.K. Pinckard, and M.R. Wick Tumor-related thrombotic pulmonary microangiopathy: review of pathologic findings and pathophysiologic mechanisms Ann Diagn. Pathol. 4 2000 154 157
14. M.J. Quinn, T.V. Byzova, J. Qin, E.J. Topol, and E.F. Plow Integrin alphaIIbbeta3 and its antagonism Arterioscler. Thromb. Vasc. Biol. 23 2003 945 952
15. S. Rahman, A. Aitken, G. Flynn, C. Formstone, and G.F. Savidge Modulation of RGD sequence motifs regulates disintegrin recognition of alphaIIb beta3 and alpha5 beta1 integrin complexes. Replacement of elegantin alanine-50 with proline, N-terminal to the RGD sequence, diminishes recognition of the alpha5 beta1 complex with restoration induced by Mn2+ cation Biochem. J. 335 1998 247 257
16. C.R. Ramos, P.A. Abreu, A.L. Nascimento, and P.L. Ho A high-copy T7 Escherichia coli expression vector for the production of recombinant proteins with a minimal N-terminal His-tagged fusion peptide Braz. J. Med. Biol. Res. 37 2004 1103 1109
17. M.A. Schwartz, and M.H. Ginsberg Networks and crosstalk: integrin signalling spreads Nat. Cell Biol. 4 2002 E65 E68
18. E.J. Topol, T.V. Byzova, and E.F. Plow Platelet GPIIb-IIIa blockers Lancet 353 1999 227 231
19. M. Trikha, J. Timar, S.K. Lundy, K. Szekeres, Y. Cai, A.T. Porter, and K.V. Honn The high affinity alphaIIb beta3 integrin is involved in invasion of human melanoma cells Cancer Res. 57 1997 2522 2528
20. C.L. Wagner, M.A. Mascelli, D.S. Neblock, H.F. Weisman, B.S. Coller, and R.E. Jordan Analysis of GPIIb/IIIa receptor number by quantification of 7E3 binding to human platelets Blood 88 1996 907 914
21. I. Wierzbicka-Patynowski, S. Niewiarowski, C. Marcinkiewicz, J.J. Calvete, M.M. Marcinkiewicz, and M.A. McLane Structural requirements of echistatin for the recognition of alpha(v)beta(3) and alpha(5)beta(1) integrins J. Biol. Chem. 274 1999 37809 37814
22. C.F. Wu, H.J. Cha, G. Rao, J.J. Valdes, and W.E. Bentley A green fluorescent protein fusion strategy for monitoring the expression, cellular location, and separation of biologically active organophosphorus hydrolase Appl. Microbiol. Biotechnol. 54 2000 78 83